Your browser is no longer supported. Please, upgrade your browser.
Settings
ITUS ITUS Corporation daily Stock Chart
ITUS [NASD]
ITUS Corporation
Index- P/E- EPS (ttm)-0.60 Insider Own0.10% Shs Outstand17.46M Perf Week20.74%
Market Cap85.38M Forward P/E- EPS next Y- Insider Trans-15.32% Shs Float16.22M Perf Month24.11%
Income-10.50M PEG- EPS next Q- Inst Own4.80% Short Float10.70% Perf Quarter53.77%
Sales1.10M P/S77.62 EPS this Y-0.20% Inst Trans7.16% Short Ratio13.73 Perf Half Y17.83%
Book/sh0.34 P/B14.38 EPS next Y- ROA-135.40% Target Price1.12 Perf Year138.54%
Cash/sh0.31 P/C15.81 EPS next 5Y- ROE-156.70% 52W Range1.83 - 6.43 Perf YTD107.20%
Dividend- P/FCF- EPS past 5Y0.30% ROI-57.30% 52W High-23.95% Beta-0.59
Dividend %- Quick Ratio5.10 Sales past 5Y-17.40% Gross Margin- 52W Low167.21% ATR0.34
Employees7 Current Ratio5.10 Sales Q/Q0.00% Oper. Margin- RSI (14)68.51 Volatility9.66% 8.29%
OptionableNo Debt/Eq0.00 EPS Q/Q-141.10% Profit Margin- Rel Volume1.60 Prev Close4.67
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume126.33K Price4.89
Recom- SMA2021.27% SMA5031.70% SMA20034.52% Volume201,869 Change4.71%
Sep-05-18 07:00AM  Moffitt Cancer Center and ITUS Corporation Announce Scheduling of Pre-IND Meeting with the FDA for their CAR-T Therapy PR Newswire +5.54%
Aug-17-18 07:00AM  ITUS Corporation to Present at Next Generation Dx Summit PR Newswire
Aug-01-18 07:00AM  Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy PR Newswire
Jul-30-18 07:00AM  ITUS Corporation Releases Results for Cchek Breast Cancer Study PR Newswire
Jul-06-18 08:00AM  ITUS Corporation Announces Second Commercial Focus for Cchek will be Breast Cancer PR Newswire
Jun-29-18 08:00AM  ITUS to Ring the NASDAQ Closing Bell on July 5th PR Newswire
Jun-26-18 08:00AM  ITUS Accelerates Schedule for its CAR T Therapy and Provides Update PR Newswire
Jun-13-18 08:00AM  ITUS Corporation Announces First Commercial Focus for Cchek will be Prostate Cancer PR Newswire +7.98%
Jun-12-18 08:30AM  ITUS Corp. (ITUS) Stock: A Disruptive Force In Cancer Diagnostics And Immunotherapy ACCESSWIRE
May-18-18 07:35AM  Complimentary Technical Snapshots on Fiserv and Three More Business Services Stocks ACCESSWIRE
May-02-18 07:30PM  Who Really Owns ITUS Corporation (NASDAQ:ITUS)? Simply Wall St.
May-01-18 07:00AM  ITUS Corporation to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and ReedSmith ACCESSWIRE
Apr-02-18 07:00AM  ITUS Presentation to Special Meeting of Stockholders PR Newswire
Mar-27-18 07:00AM  ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study PR Newswire -21.36%
Mar-26-18 07:00AM  ITUS Announces Issuance of Second Key Cancer Detection Technology Patent PR Newswire
Mar-20-18 10:30AM  Where ITUS Corporation (NASDAQ:ITUS) Stands In Earnings Growth Against Its Industry Simply Wall St. -7.59%
Mar-16-18 07:00AM  ITUS to Present Data from Early Cancer Detection Study Utilizing Artificial Intelligence at the American Association of Immunologists (AAI) Meeting PR Newswire
Mar-12-18 07:00AM  ITUS will Present Data at the American Association of Cancer Research (AACR) Annual Meeting PR Newswire +10.04%
Mar-09-18 07:00AM  ITUS Corporation to Present at the 2018 Inaugural China Healthcare Investment & Partnering Symposium (CHIPS) PR Newswire
Mar-05-18 07:00AM  ITUS Corporation Forms Alliance with Serametrix Corporation PR Newswire +17.79%
Feb-07-18 07:00AM  ITUS will Present Artificial Intelligence Powered Early Cancer Detection Technology at the Keystone Symposia Conference - Cancer Immunotherapy: Combinations PR Newswire -6.58%
Jan-31-18 07:00AM  Blog Exposure - ITUS Presents Positive Data from its Early Cancer Detection Technology at ASCO-SITC Symposium ACCESSWIRE -7.90%
Jan-30-18 01:37PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of ITUS Corporation Business Wire
Jan-29-18 07:00AM  ITUS Presents Positive Data from its Early Cancer Detection Technology at ASCO-SITC Symposium PR Newswire -31.57%
Jan-28-18 07:26PM  Is ITUS Corporation (NASDAQ:ITUS) Thriving Or Barely Surviving In The Tech Sector? Simply Wall St.
Jan-22-18 07:00AM  ITUS Will Present Early Cancer Detection Data at ASCO-SITC Symposium on January 26 PR Newswire +9.41%
Jan-19-18 01:25PM  Who Are The Major Shareholders Of ITUS Corporation (NASDAQ:ITUS)? Simply Wall St. -5.56%
Dec-18-17 06:45PM  Is ITUS Corporation (NASDAQ:ITUS) Overpaying Its CEO? Simply Wall St.
Dec-12-17 07:00AM  ITUS Corporation Terminates At-The-Market Offering PR Newswire
Dec-06-17 07:00AM  ITUS Will Present Data on Early Cancer Detection Technology at ASCO-SITC Symposium PR Newswire
Dec-05-17 09:20AM  SeeThruEquity Initiates Coverage on ITUS Corporation (NASDAQ: ITUS) with a Price Target of $5.00 ACCESSWIRE +6.61%
Dec-04-17 10:00AM  ITUS Corporation (ITUS): Should The Recent EPS Drop Worry You? Simply Wall St.
Nov-28-17 07:00AM  ITUS Receives Notice of Allowance for Second Key Cancer Technology Patent PR Newswire
Nov-23-17 07:23PM  How Moffitt could play a role in finding a treatment for ovarian cancer American City Business Journals
Nov-22-17 07:00AM  ITUS Conference Call Recording Available on Company Website PR Newswire
Nov-21-17 12:25PM  ITUS Will Hold Conference Call to Discuss its CAR-T Cancer Therapeutics Program PR Newswire
Nov-20-17 07:00AM  ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center PR Newswire +8.59%
Nov-17-17 07:54PM  What Investors Should Know About ITUS Corporations (ITUS) Financial Strength Simply Wall St.
Nov-14-17 07:00AM  ITUS Corporation Licenses CAR-T Technology from The Wistar Institute PR Newswire
Oct-27-17 07:00AM  ITUS Corporation Pays Off Secured Debenture Marketwired
Oct-16-17 08:30AM  ITUS Corporation Discusses Early Cancer Detection Technology and new CAR-T, Ovarian Cancer Initiative in New SNNLive Video Interview with StockNewsNow.com ACCESSWIRE -6.27%
Oct-03-17 06:00AM  ITUS Receives Notice of NASDAQ Continued Listing Compliance Marketwired
Oct-02-17 06:00AM  ITUS Corporation Completes At-the-Market Offering Marketwired +10.27%
Sep-26-17 06:00AM  ITUS Presentation to Annual Meeting of Stockholders Marketwired +29.61%
Sep-25-17 09:00AM  ITUS Corporation to Present at the 2017 Disruptive Growth Company Showcase NYC Presented by SeeThruEquity and RHK Capital ACCESSWIRE +69.60%
Sep-21-17 08:00AM  ITUS Provides Update on Cancer Detection Technology and New CAR-T Initiative for Ovarian Cancer Marketwired +6.21%
Sep-19-17 08:10AM  Today's Research Reports on Stocks to Watch: Itus Corporation and Nabriva Therapeutics ACCESSWIRE +50.00%
Sep-18-17 09:30AM  ITUS Corporation Announces Issuance of Patent on Cancer Detection Technology Marketwired +85.51%
Sep-12-17 03:27PM  ITUS Corp. :ITUS-US: Earnings Analysis: Q3, 2017 By the Numbers : September 12, 2017 Capital Cube
Aug-09-17 08:30AM  ITUS Corporation Provides Company Overview and Discusses the Cchek(TM) Platform in New SNNLive Video Interview with StockNewsNow.com ACCESSWIRE -10.00%
Aug-07-17 09:00AM  The Wistar Institute and ITUS Corporation Renew Collaborative Research Agreement Marketwired
Jul-18-17 06:30PM  Lew Titterton re-joins ITUS Corporation's Board of Directors Marketwired
Jul-07-17 09:02AM  ITUS Appoints Dr. Amit Kumar as New CEO and Announces Management Changes Marketwired
Jun-01-17 07:20PM  ITUS Corporation to Present at the 7th Annual LD Micro Conference Marketwired
May-30-17 09:00AM  ITUS Corporation to Present at WallStreet Research Hosted Event on May 31 in Los Angeles Marketwired
May-17-17 09:30AM  Dawson James Securities Announces the Closing of Public Offering with ITUS Corporation for Gross Proceeds of $3,596,645 Million Accesswire -9.09%
May-16-17 01:38PM  ITUS Corporation Successfully Completes $3.6 Million Public Offering Marketwired
May-11-17 08:22AM  ITUS Corporation Announces Pricing of Public Offering of up to 3.5 million shares of Common Stock Marketwired -33.82%
May-10-17 05:16PM  ITUS Corporation Announces Proposed Public Offering of Common Stock Marketwired +47.83%
02:28PM  ITUS Receives Notice of Allowance for First Cancer Technology Patent Marketwired
May-09-17 08:00AM  ITUS Extends its Collaboration with Virtua Healthcare System Marketwired
Apr-06-17 11:17AM  ITUS Presents at American Association of Cancer Research Conference Marketwired -6.32%
Apr-04-17 04:54PM  ITUS Announces Closing of Rights Offering Marketwired -8.47%
Mar-28-17 10:30AM  Cancer May Have No Where to Hide Evaluating ITUS Corp Platform Accesswire +6.15%
Mar-22-17 01:04PM  ITUS CORP Financials -6.83%
Mar-20-17 06:00AM  ITUS Early Cancer Detection Biomarker Study Expands to Include Abramson Cancer Center Researchers Marketwired
Mar-16-17 06:09AM  ITUS CORP Files SEC form 10-Q, Quarterly Report
Mar-13-17 07:00AM  ITUS Rights Offering Materials Available for Shareholders of Record Marketwired -5.88%
Mar-08-17 06:04AM  ITUS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits +5.56%
Mar-07-17 08:45AM  The Delaware Valley Urology Cancer Treatment Center Joins ITUS Early Cancer Detection Biomarker Study Marketwired
Feb-23-17 07:30PM  ITUS Announces February 24, 2017 is the Ownership Day for the ITUS Rights Offering Marketwired
Feb-21-17 08:45AM  ITUS Corporation to Present Data at the American Association of Cancer Research National Conference Marketwired
Feb-14-17 05:31PM  ITUS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-10-17 08:45AM  ITUS Extends Ownership Period and Changes Record Date for Stock Rights Offering Marketwired +11.83%
Feb-09-17 08:45AM  ITUS to Present at UK Biotech Capital Conference Marketwired
Feb-07-17 08:45AM  ITUS to Present at 2nd Annual Disruptive Growth & Healthcare Conference Marketwired
Feb-06-17 12:58PM  ITUS to Present at BIO CEO & Investor Conference Marketwired
Jan-30-17 08:15AM  ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with Prostate Cancer Marketwired
Jan-24-17 01:45PM  ITUS to Present at Noble Investor Conference Marketwired +6.59%
Jan-23-17 08:30AM  ITUS Board Member Dr. Arnold Baskies Appointed Chairman of the American Cancer Society Marketwired
Jan-19-17 08:55AM  ITUS Announces Common Stock Rights Offering and Ownership Day Marketwired -12.38%
08:10AM  ITUS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-09-17 01:33PM  ETFs with exposure to ITUS Corp. : January 9, 2017
Dec-30-16 11:11AM  ETFs with exposure to ITUS Corp. : December 30, 2016
Dec-29-16 07:57AM  ITUS Corp. :ITUS-US: Earnings Analysis: 2016 By the Numbers : December 29, 2016
Dec-14-16 01:11PM  ETFs with exposure to ITUS Corp. : December 14, 2016
01:04PM  ITUS CORP Financials
Dec-08-16 01:53PM  ITUS CORP Files SEC form 10-K/A, Annual Report +10.19%
Dec-07-16 08:24PM  MD Anderson Cancer Center Joins ITUS Early Cancer Detection Biomarker Study Marketwired
06:45AM  ITUS Announces Cchek(TM) Preliminary Cancer Patient Efficacy Study Results Marketwired
06:43AM  ITUS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:38AM  ITUS CORP Files SEC form 10-K, Annual Report
Nov-30-16 09:00AM  ITUS Executive Chairman Dr. Amit Kumar Appointed to American Cancer Society National Board of Directors Marketwired
Nov-15-16 09:00AM  ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with 6 Additional Cancer Types Marketwired -8.49%
Oct-25-16 09:00AM  ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with Pancreatic Cancer Marketwired +6.54%
Oct-24-16 09:00AM  ITUS Hires Michael Catelani as Chief Financial Officer Marketwired -6.14%
Oct-21-16 04:07PM  ITUS CORP Files SEC form 8-K, Change in Directors or Principal Officers -10.94%
Oct-18-16 11:21AM  ITUS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +6.90%
Oct-17-16 01:01PM  ITUS Receives Notice of NASDAQ Continued Listing Compliance Marketwired
Oct-12-16 09:00AM  ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Thyroid Cancer Marketwired +11.11%
ITUS Corporation develops, acquires, and licenses emerging technologies in the areas of biotechnology. The company develops Cchek, a platform for non-invasive blood tests for the early detection of various cancers, including breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar, and prostate cancer. It also develops immuno-therapy drugs for the treatment of cancer. The company was formerly known as CopyTele, Inc. and changed its name to ITUS Corporation in September 2014. ITUS Corporation was founded in 1982 and is based in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Catelani MichaelCOO & CFOSep 18Buy4.452,25010,0132,250Sep 19 11:47 AM
Titterton Lewis H jrDirectorSep 14Buy3.985,00019,900839,544Sep 17 11:18 AM
KUMAR AMITChief Executive OfficerSep 14Buy4.083,00012,240139,000Sep 18 11:19 AM
KUMAR AMITChief Executive OfficerSep 13Buy3.843,00011,520136,000Sep 14 09:54 AM
KUMAR AMITChief Executive OfficerSep 13Buy3.964,11216,284133,000Sep 13 12:49 PM
KUMAR AMITChief Executive OfficerSep 12Buy3.994,48017,875128,888Sep 12 07:13 PM
WILLIAMS RICHARD HDirectorApr 09Sale4.6425,000116,00025,000Apr 11 05:39 PM
Titterton Lewis H jrDirectorOct 19Option Exercise0.672,4001,608834,544Oct 23 05:54 PM